Skip to main content
Premium Trial:

Request an Annual Quote

Swift Biosciences Normalase Amplicon SARS-CoV-2 S Gene Panel

Swift Biosciences has released the Normalase Amplicon SARS-CoV-2 S Gene Panel (SNAP), a targeted gene panel that covers 100 percent of the SARS-CoV-2 S gene even with limited viral titers. The new panel eliminates the need to perform qPCR for library normalization for downstream sequencing, Swift said.

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.